Effect of Yong Chong Cao Capsule on Outcomes in Patients With Mild to Severe COPD
Condition: Pulmonary Disease, Chronic Obstructive Interventions: Drug: Salbutamol (Ventolin®); Drug: Tiotropium Bromide (Spiriva®); Drug: Salmeterol / fluticasone (Seretide®); Drug: YCC capsule; Drug: BL capsule Sponsors: Henan University of Traditional Chinese Medicine; Jiangsu Famous Medical Technology Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Chronic Obstructive Pulmonary | Research